News | February 05, 2022
Expert panel recommends Emergency Use Authorisation for Sputnik Light
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Lupin has reported consolidated financial results for the period ended December 31, 2021
The company has reported standalone financial results for the period ended December 31, 2021.
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Dr. Reddy’s included in S&P Global’s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row
Subscribe To Our Newsletter & Stay Updated
